Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Inclusion Criteria * Subjects (male and female) with non-cystic fibrosis bronchiectasis (NCFB) or chronic obstructive pulmonary disease (COPD) * Subjects must be aged ≥40 * Subject must be able to independently manage and administer their NCFB/COPD medications Exclusion Criteria: * Subjects with recent exacerbation * Subjects with recent significant hemoptysis in the four weeks before screening (and/or during the screening period) * Subjects allergic to quinine * Known chronic bronchial asthma